Eledon Pharmaceuticals, Inc.
ELDN
$3.57
-$0.01-0.27%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.04% | -4.88% | 19.45% | 28.66% | 191.36% |
| Total Receivables | -23.39% | -17.76% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.33% | -35.28% | -25.83% | -9.70% | -60.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -83.64% | -89.42% | -96.83% | -93.63% | 1.85% |
| Total Current Assets | -11.07% | -5.60% | 18.15% | 27.73% | 166.21% |
|
|
|||||
| Total Current Assets | -11.07% | -5.60% | 18.15% | 27.73% | 166.21% |
| Net Property, Plant & Equipment | -37.65% | -33.80% | 47.35% | 24.48% | 214.81% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -50.00% | -11.29% | 126.67% | 35.69% | 91.35% |
| Total Assets | -9.08% | -4.73% | 13.34% | 20.27% | 99.59% |
|
|
|||||
| Total Accounts Payable | 126.99% | -37.82% | -21.04% | 171.46% | 55.63% |
| Total Accrued Expenses | 9.15% | 164.44% | 44.70% | 109.31% | 183.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.54% | 14.01% | 86.02% | 24.91% | 14.44% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 46.52% | 58.45% | 14.47% | 127.70% | 116.27% |
|
|
|||||
| Total Current Liabilities | 46.52% | 58.45% | 14.47% | 127.70% | 116.27% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -66.49% | -55.78% | 19.37% | 20.98% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -11.96% | -71.09% | -6.16% | -79.85% | -59.49% |
| Total Liabilities | -1.11% | -45.62% | 0.74% | -69.86% | -51.09% |
|
|
|||||
| Common Stock & APIC | 28.45% | 13.57% | 24.52% | 26.34% | 28.23% |
| Retained Earnings | -21.58% | -12.83% | -25.66% | 3.77% | -5.55% |
| Treasury Stock & Other | -300.00% | -7.69% | -91.18% | -- | -- |
| Total Common Equity | 70.60% | 15.78% | 19.72% | 1,347.24% | 499.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 70.60% | 15.78% | 19.72% | 1,347.24% | 499.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.33% | 15.78% | 19.72% | 1,347.24% | 877.97% |
|
|
|||||